Sherbrooke Park Advisers’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
+12,658
| New | +$113K | 0.05% | 450 |
|
|
2025
Q1 | – | Sell |
-34,628
| Closed | -$260K | – | 619 |
|
|
2024
Q4 | $260K | Buy |
34,628
+7,134
| +26% | +$53.6K | 0.08% | 467 |
|
|
2024
Q3 | $209K | Buy |
+27,494
| New | +$209K | 0.05% | 736 |
|
|
2024
Q2 | – | Sell |
-78,814
| Closed | -$400K | – | 913 |
|
|
2024
Q1 | $400K | Buy |
78,814
+66,051
| +518% | +$336K | 0.08% | 443 |
|
|
2023
Q4 | $76.5K | Buy |
+12,763
| New | +$76.5K | 0.04% | 419 |
|